Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
FocusonSepsis
LivioPaganoIstitutodiEmatologia-PolodiOnco-Ematologia
FondazionePoliclinicoAgostinoGemelliUniversitàCattolicaS.Cuore
Roma
SurvivingSepsisandSepticShock
v Mortality rates associated with sepsis
v 30-50% for severe sepsis
v 50-60% for septic shock
v Severe sepsis is the leading cause of death in the non-coronary ICU
v Sepsis kills approximately 1,400 people worldwide every day
v 2013 NYS DOH issues a mandate for all hospitals to produce clinical care guidelines
for evidence-based recognition and treatment of sepsis.
v Adult and Pediatric treatment protocols for both ED and inpatient.
v Education of hospital staff: Physician/Resident, RN, Pharm, Laboratory.
v Data submission for public reporting of outcomes.
• Sepsiscanleadtoshockandorganfailure,andisaleadingcauseofdeathintheUnitedStateswithamortalityrateofapproximately30%,almostdoublethemortalityrateofacutemyocardialinfarction,orheartattack.1
• Sepsisisthemostexpensivehospital-treatedconditionintheUnitedStates–representingover$20.3billioninhealthcarecosts.2Over1.6millionpatientsintheUSalonearediagnosedwithsepsiseachyearandapproximately500,000diefromthisillness.3
• Thehighcostoftreatingsepsisisprimarilydrivenbytheextendedhospitalizationofpatientswhichtypicallyincludesover7daysintheIntensiveCareUnit.4
CostofSepsis
1.JAntimicrobChemother2011;66Suppl2:ii11–ii23doi:10.1093/jac/dkq5152.HCUPStatisticalBrief#160.August2013.AgencyforHealthcareResearchandQuality,Rockville,MD.3.HCUPStatisticalBrief#122.October2011.AgencyforHealthcareResearchandQuality,Rockville,MD.4.Martin,J.B.,Wheeler,A.P.(2009).Approachtothepatientwithsepsis.Clin.ChestMed.,30(1),1-16.
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
Acontinuumofseveritydescribingthehostsystemicinflammatoryresponse
SIRS
² SIRS–systemicinflammatoryresponsesyndrome² Musthaveatleast2ofthefollowing:
² Temperature>38.5ºCor<36ºC² Heartrate>90beats/min² Respiratoryrate>20breaths/minorPaCO2<32mmHg² WBC>12,000cells/mm3,<4000cells/mm3,or>10%immature(band)forms
² SIRSisthebody’sresponsetoinfection,inflammation,stress
SepsisandSevereSepsis
v Sepsis–SIRS+suspectedorconfirmedinfection(documentedviaculturesorvisualizedviaphysicalexam/imaging)
v SevereSepsis–Sepsis+atleastonesignoforganhypo-perfusionordysfunction
Areas of mottled skin Disseminated intravascular coagulation Capillary refill > 3 secs AKI UOP < 0.5cc/kg /hr ARDS or acute lung injury (ALI) Lactate > 2mmol /L Cardiac dysfunction on echo Altered mental status Plt < 100 Abnormal EEG Troponin Leak
SepticShock
² SepticShock-Severesepsisplusoneofthefollowingconditions:– MAP<60mmHg(<80mmHgifprevioushypertension)afteradequatefluidresuscitation
– NeedforpressorstomaintainBPafterfluidresuscitation
– Adequatefluidresuscitation=40to60mL/kgsalinesolution(NS5L-10L)
– Lactate>4mmol/L
15
SevereSepsis
RelationshipBetweenSIRS,SepsisandSevereSepsis
BoneRCetal.Chest.1992;101:1644-55.
Trauma
Infection
SepsisOther
Pancreatitis
Burns
SIRS
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
PredisposingUnderlyingDiseases
² Heartdisease-rheumaticorcongenital² Splenectomy² Intraabdominalsepsis² Septicabortionorpelvicinfection² Intravenousdrugabuse² Immunocompromised
OrganismsResponsibleforSepticShockinRelationtoHostFactors
Asplenia EncapsulatedorganismsPneumococcusspp.,Haemophilusinfluenzae,Neisseriameningtidis,CapnocytophagiacanimorsusBabesiosis
Cirrhosis Vibrio,Yersinia,andSalmonellaspp.,otherGram-negativerods(GNRs),encapsulatedorganisms
Alcoholism Klebsiellaspp.,pnemococcus
Diabetes MucormycosisandPseudomonasssp.malignantexternalotitis,Escherichiacoli
Steroids Tuberculosis,fungi,herpesvirusNeutropenia EntericGNR,Pseudomonas,Aspergillus,
Candida,andMucorspp.,Staphylococcusaureus
T-cellabnortmalities
Listeria,Salmonella,andMycobacteriaspp.,herpesvirusgroup(herpessimplexvirus,cytomegalovirus,varicellazostervirus)
TheEpidemiologyofSepsisintheUnitedStatesNumberofcasesofsepsisintheUnitedStates,accordingtothecausativeorganism,1979-2000
NEnglJMed2003;348:1546-1554
EmergenceofGram-NegativeOrganisms
² Antibioticpressureonnormalflora² Useofinvasivedevices² Immunesuppression
Resistancetothird-generationcephalosporinsEurope,2014K. pneumoniae E. coli
EARS-NET
History
² Communityversushospital-acquired² Priororcurrentmedications² Recentmanipulationsorsurgery² Underlyingdiseases² Travelhistory
Sourcesofsepsis
v Respiratory 38%v Urinarytract 21%v Intra-abdominal16.5%v CRBSI 2.3%v Device 1.3%v CNS 0.8%v Others 11.3%
Non tunneled CVC extraluminal colonization intraluminal contamination
Tunneled CVC
intraluminal infection
Candida Staphylococcus
Themainproblemarenosocomialinfections!!
GI tractGI tract
insult
injury
translocation
infection
antibiotics
selection
Normalcommensalflora
Disease
Centralvenouscatheter
Candidaandbacterialspecies
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
SepsisPathogenesis
Unbalanced Immune Reaction
Tissue Factor
Procoagulant State
Microvascular Thrombosis
Mediators of Inflammation
ROS
Vasodilation Capillary Leak
DIC
BacterialcomponentsinthepathogenesisofSepticShock
BacterialcomponentsSourceEndotoxin(LPS,lipidA) Allgram-bacteriaPeptidoglycan Allbacteria
Lipoteichoicacid Gram+bacteriaPore-formingExotoxins S.aureus,S.pyogenes
E.coliSuperantigens S.aureus,S.pyogenesEnzymes S.pyogenes,C.perfringens
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
ClinicalManifestations
² Fever,chills,hypotension² Hypothermia,especiallyintheelderly² Hyperventilation-respiratoryalkalosis² Diaphoresis,apprehension,changeinmentalstatus
Skin
v Furuncles,cellulitis,bullouslesionsv Intravenoussites,phlebitisv Erythemamultiformev Ecchymoticorpurpuriclesionsv DIC,petechiaev Ecthymagangrenosumv Purpurafulminans
CardiovascularSigns
v “Warmshock”-↑CO,↓SVRv “Coldshock”-↓CO,↑SVRv Anaerobicmetabolism-lacticacidemia
PulmonarySigns
v Tachypneav Hyperventilation,respiratoryalkalosisv ARDS,respiratoryfailurev Ventilation-perfusionmismatchv Widenedalveolar-arterialoxygengradientv Reducedlungcompliance
RenalandGastrointestinalSigns
v Acutetubularnecrosis,oliguria,anuriav UpperGIbleedingv Cholestaticjaundicev Increasedtransaminaselevelsv Hypoglycemia
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
Sepsisiscurrentlydiagnosedusingclinicaldefinitionscombinedwith
cultureresults
Timeisacrucialpoint!!
DiagnosticstrategiesforrapididentificationofBSIs
AutomatedinstrumentsBloodcultures
Detectionofmicrobialgrowth
Time
ID/AST
Culture-basedmethods
Gramstaining
MALDI-TOFMS MolecularmethodstointegrateMALDIandto
detectresistancedeterminants
AST
Infectiousdiseaseconsultant
BSI,bloodstreaminfection;ID,identification;AST,antimicrobialsusceptibilitytesting;MALDI-TOFMS,matrix-assistedlaserdesorptionionizationtime-of-flightmassspectrometry
Infectiousdisease
consultant
RoleofProcalcitonininsepsis² Alternative(cytokine-like)pathwayduringsepsis:‘Hormokine’² Bacterialtoxins(gran+/gram-)andcytokinesstimulateproductionof
Procalcitonininallparenchymaltissues² Thisprocesscanbeattenuatedorblockedduringviralinfectionbyinterferones.² NonendocrinetissueieLiver,Lung,Brainetc.donothaveendocrinegranules
wherecalcitonincanbestored.² PCTisimmediatelyreleasedintothebloodstream
PCT
² Hasbactericidalproperties² Presentinallmammalstested² Probablywasanearlyhostdefenseagainstinfection
² Replacedbymorerobustdefensessuchasantibodysystemandenhancedleukocytedefenses
² Mostimportant,perhaps,indefendingthebodyagainstinvasionofbacteriaduringfeeding.
• Howcanweusethiscellularsignalofinfectioninthemanagementofbothsepticandnonsepticpatients
• Goals
– Provideantibiotictherapytoptswhoneeditassoonaspossible– Avoidantibioticprescriptiontothosewithoutinfection– Dobothwithastronglikelihoodofbeingcorrect,atleastasgoodasothermarkerssuchasWBC,bands,fever,CRP
PCTkineticsprovideimportantinformationonprognosisofsepsispatients
• Clinical symptoms alone are often insufficient for early and accurate diagnosis • PCT levels, can be observed within 3-6 hours after an infectious challenge with a
peak - up to 1000 ng/ml - after 6-12 hrs. Half-life: ~24hrs • Specific to bacterial origin of infection and reflects the severity of the infection
Brunkhorst FM et al., Intens. Care Med (1998) 24: 888-892
Harbarth S et.al. AM J Resp Crit Care Med. 2001; 164:396-402
WhenPCTisusedasareference,thesensitivityandspecificityofsepsisdiagnosiscanbesignificantlyincreasedcomparedwithconventionalclinicalparameters.
Sensitivity:94%Specificity:77%
Adding PCT results to clinical assessment improves the accuracy of the early clinical diagnosis of sepsis
C-ReactiveProtein(CRP)
v Anadditionalinflammatorymarkeravailableforsepsisscreening
v AriseintheplasmaconcentartionofCRPinabsenceofothernon-infectiouscausesofinflammation(i.e.trauma,surgery,etc)maybesuggestiveofinfection
v SevereliverdiseasemayreducethelevationofCRP.Intheseindivuduals,diagnosisofsepsisshouldnotbeexcludedbasedonlowerCRP
Lactate
• Thebody’senergyneedsmainlymetbyaerobicmetabolism,whichrequiredoxygen
• Ifthereisalackofoxygenitreverttoanerobicmetabolismwhichlacticacidisproduct
• ThismayleadtoacidosiswithadecreaseofpH
• EvidenceisclearthatLactatelevelsarepredictiveofdeathandMODS
• Clearanceoflactateisassociatedwithimprovedsurvival• Algorithmsofcarebasedonlactateclearanceappearto
workaswellorbetterthanotherapproaches.
Simon L. et al. Clin Infect Dis. 2004; 39:206-217.
AddingPCTresultstoclinicalassessmentimprovestheaccuracyoftheearlyclinicaldiagnosisofsepsis
• PCTlevelsaccuratelydifferentiatesepsisfromnoninfectiousinflammation*• PCThasbeendemonstratedtobethebestmarkerfordifferentiatingpatientswithsepsisfromthosewith
systemicinflammatoryreactionnotrelatedtoinfectiouscause
Sensitivity:89%Specificity:94%
NPV:90%PPV:94%
TCI, time to culture-based identification results ; TDI, time to direct identification results.
Timetoidentification
v Themediantimetopositivitywas12.2hours(IQR:8.2-17.5),rangingfrom10.4h(IQR:7-15.1)forGram-negativebacteria,to15.2h(IQR:10.3-18.5)forGram-positiveisolates.Itwas16.4h(IQR:10.3-28)foryeastsand10.5h(IQR:6-16)forpolymicrobialcultures.
v Themediantimetoidentificationforthedirectmethodwas19.5hours(IQRs:14.3-26.5h)(range:17.2hforGram-negativesto21.5hforgram-positivesandyeasts)andthatforthecomparisonculture-basedmethodwas41.7h(IQRs,35.5-53h)
020
40
60
80
100
hours
Gram-negative Gram-positive Yeast mixed
TCI TDI
Using our IPF% reference normal range [IPF% 2.39% (0.8-5.1)], a significantly (p<0.0001) higher level of IPF% in samples with positive BC [IPF% 4.86% (2.4-15.8)] than in negative
samples [IPF% 1.79% (0.5-4.7)] was found Increased IPF% significantly correlates with BCs positivity.
v Definitionv Epidemiologyv PathogeneticMechanismsv SignsandSymptomsv Laboratoryv Outcomeandtreatment
FactorsAssociatedwithHighestMortality
v Respiratory>abdominal>urinaryv Nosocomialinfectionv Hypotension,anuriav Isolationofenterococciorfungiv Gram-negativebacteremia,polymicrobialv Bodytemperaturelowerthan38°Cv Agegreaterthan40v Underlyinghematologicalmalignancy
SevereSepsisRecommendations
AdultandPediatricEvidence-basedStudies
1. EarlyDetection2. EarlyTreatment
• SepsisResuscitationBundle
3. Monitorreliabilityandoutcomes
Earlyantibioticsaregood
Author N Setting Mediantime(mins)
Oddsratiofordeath
GaieskiCCM2010;38;1045-53
261 ED,USA(shock)
119 0.30(1sthourvsalltimes)
DanielsEmergMedJ2010;doi:10.1136
567 Wholehospital,UK
121 0.62(1sthourvsalltimes)
KumarCCM2006;34(6):1589-1596
2154 ED,Canada(shock)
360 0.59(1st3hoursvsdelayed)
AppelboamCCM2010;14(Suppl1):50
375 Wholehospital,UK
240 0.74(1st3hoursvsdelayed)
LevyCCM2010;38(2):1-8
15022 Multi-centre 0.86(1st3hoursvsdelayed)
Rapiddetectionofsepsishaveagreat
impactonthesurvivalofpatients
FungalinfectionsMorrelletal.,AAC,2005
BacterialsepsisKumaretal.,Clin.CareMed.,2006
VariablesindependentlyassociatedwithmortalityofBSIs.Logisticregressionanalysis
v inadequateinitialantimicrobialtherapy(OR,6.28;95%CI,3.18to12.42;P<0.001)
v unidentifiedprimaryinfectionsite(OR,2.69;95%CI,1.38to5.27;P=0.004).
Tumbarelloetal.AntimicrobAgentsChemother2007
InappropriateAntimicrobialTherapy:ImpactonMortality
Kollefetal:Chest2002
0
100
200
300
400
500
600
No.In
fected
Pa
tients
42.0%mortality
17.7%mortality
RelativeRisk=2.37(95%C.I.1.83-3.08;P<.001)
#Deaths
#Survivors
InappropriateTherapy
AppropriateTherapy
N Engl J Med, Vol. 347, No. 13·September 26, 2002
Mortality
Septic Shock Outcomes for Patients on Hospital Wards versus
ICU’s • Wardpatients: DelaysinICUtransfer(67mins.) IVfluidboluses(27vs15mins.) Inotropicagents(310vs22.5mins)
• Mortality: Wards(70%)vsICUs(39%) ApacheIIscores(18.5vs24) Candidemia
JSLunberg,Crit.CareMed.1998